What We're Reading: Page 30
Industry reads hand-picked by our editors
May 22, 2025
-
Reuters
Prices for new US drugs doubled in 4 years as focus on rare disease grows
-
The Wall Street Journal
What’s Inside RFK Jr.’s MAHA Report
-
KFF Health News
Trump Won’t Force Medicaid to Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.
-
Nature
#OpenToWork: how laid-off US scientists are coping with shattered careers
May 21, 2025
May 20, 2025
-
The Wall Street Journal
The Next Frontier to Treat Cancer: Electricity
-
The Financial Times
More than 120 countries back treaty to share vaccines in pandemics
-
Nature
AI tool flags people at high risk of postpartum depression
May 19, 2025
-
Bloomberg
Zepbound Craze Boosts $80 Billion Lilly Endowment to Largest in US
-
Fierce Biotech
Boehringer’s phase 3 lung data get muted response from analysts
-
MIT Technology Review
The first US hub for experimental medical treatments is coming
May 16, 2025
-
The Wall Street Journal
HHS to Stop Recommending Routine Covid Shots for Children, Pregnant Women
-
The Boston Globe
Empty lab space keeps piling up around Greater Boston
-
MIT Technology Review
Access to experimental medical treatments is expanding across the US
May 15, 2025
-
Chemical & Engineering News
How will FDA changes reshape drug approval in 2025 and beyond?
-
Bloomberg
Merck KGaA Lowers Outlook on Tariff Risks, Currency Headwinds
-
The Financial Times
England’s drug approval body resists pharma pressure to loosen processes
Previous
